{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:21:24Z","timestamp":1789708884758,"version":"4.0.1"},"reference-count":149,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Chronic kidney disease is a health problem whose prevalence is increasing worldwide. The kidney plays an important role in the metabolism of minerals and bone health and therefore, even at the early stages of CKD, disturbances in bone metabolism are observed. In the course of CKD, various bone turnover or mineralization disturbances can develop including adynamic hyperparathyroid, mixed renal bone disease, osteomalacia. The increased risk of fragility fractures is present at any age in these patients. Nutritional treatment of patients with advanced stages of CKD is aiming at prevention or correction of signs, symptoms of renal failure, avoidance of protein-energy wasting (PEW), delaying or prevention of the occurrence of mineral\/bone disturbances, and delaying the start of dialysis. The results of studies suggest that progressive protein restriction is beneficial with the progression of renal insufficiency; however, other aspects of dietary management of CKD patients, including changes in sodium, phosphorus, and energy intake, as well as the source of protein and lipids (animal or plant origin) should also be considered carefully. Energy intake must cover patients\u2019 energy requirement, in order to enable correct metabolic adaptation in the course of protein-restricted regimens and prevent negative nitrogen balance and protein-energy wasting.<\/jats:p>","DOI":"10.3390\/nu13062065","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T21:58:32Z","timestamp":1623880712000},"page":"2065","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Influence of Dietary Interventions on Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD)"],"prefix":"10.3390","volume":"13","author":[{"given":"Jacek","family":"Rysz","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Franczyk","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rokicki","sequence":"additional","affiliation":[{"name":"Clinic of Hand Surgery, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3322-5655","authenticated-orcid":false,"given":"Anna","family":"Gluba-Brz\u00f3zka","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/IJNRD.S191156","article-title":"Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives","volume":"12","author":"Waziri","year":"2019","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1523-1755.2004.00894.x","article-title":"The burden of kidney disease: Improving global outcomes","volume":"66","author":"Eknoyan","year":"2004","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.26502\/anu.2644-2833008","article-title":"Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)","volume":"2","author":"Mosbah","year":"2019","journal-title":"Arch. Nephrol. Urol."},{"key":"ref_5","first-page":"64","article-title":"[Chronic kidney disease\u2014Mineral and bone disorder: Why and how to control phosphate]","volume":"66","year":"2012","journal-title":"Acta Med. Croat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Iwasaki","year":"2007","journal-title":"Kidney Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1590\/0004-2730000003360","article-title":"Osteoporosis management in patient with renal function impairment","volume":"58","author":"Lima","year":"2014","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"ref_8","first-page":"514","article-title":"Chronic kidney disease--mineral and bone disorder: A complex scenario","volume":"31","author":"Miar","year":"2011","journal-title":"Nefrologia"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Liu, Z., Su, G., Guo, X., Wu, Y., Liu, X., Zou, C., Zhang, L., Yang, Q., Xu, Y., and Ma, W. (2015). Dietary interventions for mineral and bone disorder in people with chronic kidney disease. Cochrane Database Syst. Rev., CD010350.","DOI":"10.1002\/14651858.CD010350.pub2"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.09580911","article-title":"PTH\u2014A particularly tricky hormone: Why measure it at all in kidney patients?","volume":"8","author":"Garrett","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_13","first-page":"317","article-title":"Fractures in chronic kidney disease: Pursuing the best screening and management","volume":"24","author":"Goldenstein","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-005-1903-7","article-title":"In elderly men and women treated for osteoporosis a low creatinine clearance of <65 mL\/min is a risk factor for falls and fractures","volume":"16","author":"Dukas","year":"2005","journal-title":"Osteoporos. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.2010121275","article-title":"Discriminants of prevalent fractures in chronic kidney disease","volume":"22","author":"Nickolas","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1523-1755.2000.00394.x","article-title":"Risk factors for hip fracture among patients with end-stage renal disease","volume":"58","author":"Sherrard","year":"2000","journal-title":"Kidney Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic kidney disease-mineral-bone disorder: A new paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","article-title":"The Kidney Disease Outcomes Quality Initiative (K\/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association with mortality in dialysis patients","volume":"46","author":"Noordzij","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000444890","article-title":"Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients","volume":"43","author":"Soohoo","year":"2016","journal-title":"Am. J. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate prod-567 uct with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2008.248","article-title":"High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death","volume":"74","author":"Blayney","year":"2008","journal-title":"Kidney Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2215\/CJN.01560309","article-title":"Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease","volume":"4","author":"Beddhu","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","article-title":"FGF-23 as a predictor of renal outcome in diabetic nephropathy","volume":"6","author":"Titan","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Nowak, A., Friedrich, B., Artunc, F., Serra, A.L., Breidthardt, T., Twerenbold, R., Peter, M., and Mueller, C. (2014). Prognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100688"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000438999","article-title":"Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis","volume":"42","author":"Scialla","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Westerberg, P.A., Tivesten, \u00c5., Karlsson, M.K., Mellstr\u00f6m, D., Orwoll, E., Ohlsson, C., Larsson, T.E., Linde, T., and Ljunggren, \u00d6. (2013). Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs). BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-85"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e016528","DOI":"10.1136\/bmjopen-2017-016528","article-title":"Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage","volume":"7","author":"Shardlow","year":"2017","journal-title":"BMJ Open"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E1636","DOI":"10.1152\/ajpendo.00396.2007","article-title":"Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice","volume":"293","author":"Liu","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1744-9987.2005.00292.x","article-title":"Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor","volume":"9","author":"Miyamoto","year":"2005","journal-title":"Ther. Apher. Dial."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_34","first-page":"229","article-title":"FGF23 promotes renal calcium reabsorption through the TRPV5 channel","volume":"33","author":"Andrukhova","year":"2014","journal-title":"EMBO J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast Growth Factor-23 Mitigates Hyperphosphatemia but Accentuates Calcitriol Deficiency in Chronic Kidney Disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI114931","article-title":"Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo","volume":"86","author":"Marx","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/ndt\/gfs050","article-title":"FGF23 and PTH\u2014Double agents at the heart of CKD","volume":"27","author":"Silver","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00467-009-1260-4","article-title":"Overview of the FGF23-Klotho axis","volume":"25","year":"2010","journal-title":"Pediatric Nephrol."},{"key":"ref_41","first-page":"275","article-title":"FGF23 and mineral metabolism, implications in CKD-MBD","volume":"32","author":"Almaden","year":"2012","journal-title":"Nefrologia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.semnephrol.2012.12.013","article-title":"Renal and extrarenal actions of Klotho","volume":"33","author":"Hu","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_43","first-page":"303","article-title":"Pathophysiology of the chronic kidney disease-mineral bone disorder","volume":"24","author":"Hruska","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1681\/ASN.2006070771","article-title":"Metabolic Bone Disease in Chronic Kidney Disease","volume":"18","author":"Martin","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1258\/acb.2012.012004","article-title":"Mineral and bone disorders in chronic kidney disease: New insights into mechanism and management","volume":"49","author":"Lewis","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","volume":"86","author":"Meir","year":"2014","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1248\/bpb.b15-00756","article-title":"The Optimal Duration of PTH(1-34) Infusion Is One Hour per Day to Increase Bone Mass in Rats","volume":"39","author":"Shimizu","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/path.4121","article-title":"Wnt signalling in kidney diseases: Dual roles in renal injury and repair","volume":"229","author":"Kawakami","year":"2013","journal-title":"J. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1359-6101(01)00010-7","article-title":"The role of the activin-follistatin system in the developmental and regeneration processes of the kidney","volume":"12","author":"Maeshima","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder","volume":"25","author":"Fang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5893514","DOI":"10.1155\/2018\/5893514","article-title":"Role of the Wnt\/\u03b2-Catenin Pathway in Renal Osteodystrophy","volume":"2018","author":"Bisson","year":"2018","journal-title":"Int. J. Endocrinol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.kint.2016.02.002","article-title":"Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease","volume":"89","author":"Agapova","year":"2016","journal-title":"Kidney Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.kint.2017.06.016","article-title":"The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease","volume":"93","author":"Williams","year":"2018","journal-title":"Kidney Int."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sugatani, T. (2018). Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092490"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2014040414","article-title":"Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial","volume":"26","author":"Moe","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrneph.2013.198","article-title":"Evaluating bone quality in patients with chronic kidney disease","volume":"9","author":"Malluche","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2003.12.004","article-title":"Osteoporosis in chronic kidney disease","volume":"43","author":"Cunningham","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.ackd.2006.10.010","article-title":"Bone health in chronic kidney disease-mineral and bone disease","volume":"14","author":"Sprague","year":"2007","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrneph.2010.33","article-title":"Metabolic acidosis: Pathophysiology, diagnosis and management","volume":"6","author":"Kraut","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfn633","article-title":"Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD","volume":"24","author":"Kovesdy","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"F811","DOI":"10.1152\/ajprenal.00115.2003","article-title":"Bone buffering of acid and base in humans","volume":"285","author":"Lemann","year":"2003","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/nep.13457","article-title":"Mineral bone disorders in chronic kidney disease","volume":"23","author":"Hou","year":"2018","journal-title":"Nephrology"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Barreto, F.C., Barreto, D.V., Stinghen, A.E.M., and Massy, Z.A. (2017). Comment on Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies. Toxins, 9.","DOI":"10.3390\/toxins9040142"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Massy","year":"2016","journal-title":"Kidney Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5935\/0101-2800.20140042","article-title":"Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients","volume":"36","author":"Barreto","year":"2014","journal-title":"J. Bras. Nefrol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3476(87)80467-5","article-title":"Effects of dietary phosphate restriction in children with chronic renal failure","volume":"111","author":"McCrory","year":"1987","journal-title":"J. Pediatr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000101004","article-title":"Phosphate restriction in diet therapy","volume":"155","author":"Takeda","year":"2007","journal-title":"Contrib. Nephrol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"(2003). K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis., 42, S1\u2013S201.","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"ref_71","unstructured":"(2009). KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., S1\u2013S130."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2215\/CJN.09250912","article-title":"Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD","volume":"8","author":"Isakova","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Mitch, W.E., and Remuzzi, G. (2016). Diets for patients with chronic kidney disease, should we reconsider?. BMC Nephrol., 17.","DOI":"10.1186\/s12882-016-0283-x"},{"key":"ref_74","first-page":"476","article-title":"Dietary intervention focused on phosphate intake in hemodialysis patients with hyperphosphoremia","volume":"77","author":"Lou","year":"2012","journal-title":"Clin. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.jrn.2003.09.008","article-title":"The effect of diet education on the laboratory values and knowledge of hemodialysis patients with hyperphosphatemia","volume":"14","author":"Ford","year":"2004","journal-title":"J. Ren. Nutr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1051-2276(03)00116-X","article-title":"A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients","volume":"13","author":"Dobbie","year":"2003","journal-title":"J. Ren. Nutr."},{"key":"ref_77","first-page":"107","article-title":"Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis","volume":"16","author":"Rozga","year":"2021","journal-title":"A Syst. Rev. Meta-Anal."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/nep.13188","article-title":"Role of dietary phosphate restriction in chronic kidney disease","volume":"23","author":"Elder","year":"2018","journal-title":"Nephrology"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Palafox-Serd\u00e1n, F., Luna-Montiel, O.A., Pablo-Franco, S.E., Guillen-Tejada, D.L., Carre\u00f1o-V\u00e1zquez, S.D., Silva Pereira, T.S., Islas Romero, L.M., Villase\u00f1or L\u00f3pez, K., Ortega-R\u00e9gules, A.E., and Jim\u00e9nez-Gardu\u00f1o, A.M. (2020). Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia. Nutrients, 12.","DOI":"10.3390\/nu12113289"},{"key":"ref_80","first-page":"89","article-title":"Organic and inorganic dietary phosphorus and its management in chronic kidney disease","volume":"4","author":"Noori","year":"2010","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000045015","article-title":"Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation","volume":"79","author":"Barsotti","year":"1998","journal-title":"Nephron"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000188606","article-title":"Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol)","volume":"70","author":"Combe","year":"1995","journal-title":"Nephron"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","article-title":"The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure","volume":"29","author":"Martinez","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1053\/ajkd.2001.20748","article-title":"National Kidney Foundation K\/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure","volume":"37","author":"Kopple","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11914-020-00581-8","article-title":"Dietary Protein Intake and Bone Across Stages of Chronic Kidney isease","volume":"18","author":"Stremke","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jand.2013.12.009","article-title":"Medical nutrition therapy in adults with chronic kidney disease: Integrating evidence and consensus into practice for the generalist registered dietitian nutritionist","volume":"114","author":"Beto","year":"2014","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.ajkd.2014.09.029","article-title":"Is there a role for ketoacid supplements in the management of CKD?","volume":"65","author":"Shah","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kalantar-Zadeh, K., Moore, L.W., Tortorici, A.R., Chou, J.A., St-Jules, D.E., Aoun, A., Rojas-Bautista, V., Tschida, A.K., Rhee, C.M., and Shah, A.A. (2016). North American experience with Low protein diet for Non-dialysis-dependent chronic kidney disease. BMC Nephrol., 17.","DOI":"10.1186\/s12882-016-0304-9"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Fois, A., Chatrenet, A., Cataldo, E., Lippi, F., Kaniassi, A., Vigreux, J., Froger, L., Mongilardi, E., Capizzi, I., and Biolcati, M. (2019). Moderate Protein Restriction in Advanced CKD: A Feasible Option in An Elderly, High-Comorbidity Population. A Stepwise Multiple-Choice System Approach. Nutrients, 11.","DOI":"10.3390\/nu11010036"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/jcem.84.2.5485","article-title":"Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction","volume":"84","author":"Combe","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2215\/CJN.07640711","article-title":"Acute effects of very-low-protein diet on FGF23 levels: A randomized study","volume":"7","author":"Torraca","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1053\/j.ajkd.2013.01.007","article-title":"Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study","volume":"61","author":"Newsome","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_93","first-page":"361","article-title":"Supplemented low-protein diets--are they superior in chronic renal failure?","volume":"85","author":"Herselman","year":"1995","journal-title":"S. Afr. Med. J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.clnu.2020.03.014","article-title":"The impact of protein diet on bone density in people with\/without chronic kidney disease: An analysis of the National Health and Nutrition Examination Survey database","volume":"39","author":"Lee","year":"2020","journal-title":"Clin. Nutr."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Bellizzi, V., Calella, P., Hern\u00e1ndez, J.N., Gonz\u00e1lez, V.F., Lira, S.M., Torraca, S., Arronte, R.U., Cirillo, P., Minutolo, R., and Mont\u00fafar C\u00e1rdenas, R.A. (2018). Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-0914-5"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Koppe, L., Cassani de Oliveira, M., and Fouque, D. (2019). Ketoacid Analogues Supplementation in Chronic Kidney Disease and Future Perspectives. Nutrients, 11.","DOI":"10.3390\/nu11092071"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s10157-018-1591-1","article-title":"Effect of essential amino acid \u043aetoanalogues and protein restriction diet on morphogenetic proteins (FGF-23 and Klotho) in 3b-4 stages chronic \u043aidney disease patients: A randomized pilot study","volume":"22","author":"Milovanova","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000185940","article-title":"Therapeutic effect of keto acids on renal osteodystrophy. A prospective controlled study","volume":"55","author":"Lindenau","year":"1990","journal-title":"Nephron"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10157-014-0947-4","article-title":"Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease","volume":"18","author":"Goto","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.jrn.2019.07.005","article-title":"The Effects of Restricted Protein Diet Supplemented With Ketoanalogue on Renal Function, Blood Pressure, Nutritional Status, and Chronic Kidney Disease-Mineral and Bone Disorder in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis","volume":"30","author":"Chewcharat","year":"2020","journal-title":"J. Ren. Nutr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11255-017-1713-9","article-title":"Effect of restricted protein diet supplemented with keto analogues in end-stage renal disease: A systematic review and meta-analysis","volume":"50","author":"Jiang","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/ndt\/gfx203","article-title":"Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease","volume":"33","author":"Marzocco","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1046\/j.1523-1755.2003.00282.x","article-title":"Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure","volume":"64","author":"Minutolo","year":"2003","journal-title":"Kidney Int."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000321376","article-title":"Effect of short-term low-protein diet supplemented with keto acids on hyperphosphatemia in maintenance hemodialysis patients","volume":"31","author":"Li","year":"2011","journal-title":"Blood Purif."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/jren.2002.35300","article-title":"A controlled trial of intermittent enteral nutrient supplementation in maintenance hemodialysis patients","volume":"12","author":"Sharma","year":"2002","journal-title":"J. Ren. Nutr."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1051-2276(03)00117-1","article-title":"Body composition of patients on a very low-protein diet: A two-year survey with DEXA","volume":"13","author":"Chauveau","year":"2003","journal-title":"J. Ren. Nutr."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S0029665118001180","article-title":"Protein and bone health across the lifespan","volume":"78","author":"Dolan","year":"2019","journal-title":"Proc. Nutr. Soc."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bone.2018.10.003","article-title":"Associations of dietary protein intake with bone mineral density: An observational study in 70,215 UK Biobank participants","volume":"120","author":"Steell","year":"2019","journal-title":"Bone"},{"key":"ref_112","first-page":"17A","article-title":"TH-OR067 Intradialytic Protein Supplementation Increases Protein Intake in Older, but Not. Younger, Hemodialysis Patients and Is Associated with Improved Hip Bone Mineral. Density","volume":"27","author":"Biruete","year":"2016","journal-title":"JASN"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.ackd.2012.11.001","article-title":"Dietary acid load: A novel nutritional target in chronic kidney disease?","volume":"20","author":"Scialla","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease","volume":"5","author":"Gutekunst","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0272-6386(97)90045-7","article-title":"The clinical spectrum of chronic metabolic acidosis: Homeostatic mechanisms produce significant morbidity","volume":"29","author":"Alpern","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2215\/CJN.08960718","article-title":"Plant-Based Diets in CKD","volume":"14","author":"Clegg","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000441072","article-title":"Dietary Patterns and CKD Progression","volume":"41","author":"Banerjee","year":"2016","journal-title":"Blood Purif."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MNH.0000000000000491","article-title":"Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease","volume":"28","author":"Goraya","year":"2019","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1159\/000371498","article-title":"The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease","volume":"40","author":"Moorthi","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000045021","article-title":"Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients","volume":"79","author":"Soroka","year":"1998","journal-title":"Nephron"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Rodriguez, M., and Aguilera-Tejero, E. (2018). Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease-Metabolic Bone Disease (CKD-MBD). Nutrients, 10.","DOI":"10.3390\/nu10121840"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/gut.18.1.64","article-title":"Significance of Ca-soap formation for calcium absorption in the rat","volume":"18","author":"Gacs","year":"1977","journal-title":"Gut"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/gut.12.12.973","article-title":"The effect of fat on calcium absorption from a mixed meal in normal subjects, patients with malabsorptive disease, and patients with a partial gastrectomy","volume":"12","author":"Agnew","year":"1971","journal-title":"Gut"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/j.jrn.2008.05.007","article-title":"Fast food, phosphorus-containing additives, and the renal diet","volume":"18","author":"Sarathy","year":"2008","journal-title":"J. Ren. Nutr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nut.2013.11.017","article-title":"Effects of low-carbohydrate, high-fat diets on apparent digestibility of minerals and trace elements in rats","volume":"30","author":"Frommelt","year":"2014","journal-title":"Nutrition"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"36881","DOI":"10.1038\/srep36881","article-title":"Energy-dense diets increase FGF23, lead to phosphorus retention and promote vascular calcifications in rats","volume":"6","author":"Raya","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Rios, R., Pineda, C., Lopez, I., Mu\u00f1oz-Casta\u00f1eda, J., Rodriguez, M., Aguilera-Tejero, E., and Raya, A.I. (2018). Phosphorus restriction does not prevent the increase in fibroblast growth factor 23 elicited by high fat diet. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198481"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00223-016-0206-7","article-title":"Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury","volume":"100","author":"Kanbay","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ijo.2017.280","article-title":"High fat diet consumption differentially affects adipose tissue inflammation and adipocyte size in obesity-prone and obesity-resistant rats","volume":"42","author":"Poret","year":"2018","journal-title":"Int. J. Obes."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semnephrol.2012.12.006","article-title":"Obesity and kidney disease: Potential mechanisms","volume":"33","author":"Wickman","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ndt\/gfm576","article-title":"Metabolic effects of two low protein diets in chronic kidney disease stage 4\u20135\u2014A randomized controlled trial","volume":"23","author":"Cianciaruso","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5414\/CNP74091","article-title":"Serum alkaline phosphatase and mortality in hemodialysis patients","volume":"74","author":"Beddhu","year":"2010","journal-title":"Clin. Nephrol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nep.13014","article-title":"The use of bone turnover markers in chronic kidney disease-mineral and bone disorders","volume":"22","author":"Chiang","year":"2017","journal-title":"Nephrology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Hruby","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J. Bone Mineral. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"109703","DOI":"10.1016\/j.pnpbp.2019.109703","article-title":"Nutrition and frailty: Current knowledge","volume":"95","author":"Feart","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000439000","article-title":"Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis","volume":"42","author":"Delgado","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2337\/diaspect.21.1.19","article-title":"Secondary Hyperparathyroidism and Chronic Kidney Disease","volume":"21","author":"Tomasello","year":"2008","journal-title":"Diabetes Spectr."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: What\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00007691-199312000-00025","article-title":"Aluminum toxicity in patients with chronic renal failure","volume":"15","author":"Alfrey","year":"1993","journal-title":"Ther. Drug Monit."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semnephrol.2012.12.018","article-title":"Management of natural and added dietary phosphorus burden in kidney disease","volume":"33","author":"Cupisti","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00198-011-1599-9","article-title":"Cardiovascular effects of calcium supplementation","volume":"22","author":"Reid","year":"2011","journal-title":"Osteoporos. Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"149","DOI":"10.23736\/S0031-0808.16.03288-2","article-title":"Keto-analogues and essential aminoacids and other supplements in the conservative management of chronic kidney disease","volume":"59","author":"Cupisti","year":"2017","journal-title":"Panminer. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1053\/j.jrn.2011.09.006","article-title":"Keto acid therapy in predialysis chronic kidney disease patients: Final consensus","volume":"22","author":"Aparicio","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11255-016-1224-0","article-title":"Back to the future: Restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health","volume":"48","author":"Kovesdy","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"ref_149","first-page":"E668","article-title":"Long-term adaptive responses to dietary protein restriction in chronic renal failure","volume":"268","author":"Tom","year":"1995","journal-title":"Am. J. Physiol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/6\/2065\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:17:07Z","timestamp":1760163427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/6\/2065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":149,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["nu13062065"],"URL":"https:\/\/doi.org\/10.3390\/nu13062065","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]}}}